Skip to content
MedsAcross

Medicine

Firvanq kit

Vancomycin · Azurity Pharmaceuticals
Available on requestPrescription onlyUS FDA Cold chain

Firvanq kit is a prescription medicine containing Vancomycin, marketed by Azurity Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store the FIRVANQ kit at refrigerated conditions, 2°C to 8°C (36°F to 46°F)…

Key facts

Active ingredient (INN)
Vancomycin
Brand
Firvanq
Dosage form
Kit
Packs
1 kit and 1 more
Marketing authorisation holder
Azurity Pharmaceuticals
Manufacturer
Azurity Pharmaceuticals
Origin register
US FDA, United States
Storage
Store the FIRVANQ kit at refrigerated conditions, 2°C to 8°C (36°F to 46°F). Do not freeze. Store reconstituted solutions of FIRVANQ at 2°C to 8°C. Protect from light.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A07AA09 Vancomycin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 January 2018
Identifiers
RxCUI 2000127, 2000133, 2000134 +1DailyMed set ID 5aca5508-b577-446c-9980-ab4c7582b4b9NDC 65628-208, 65628-206, 65628-204 +1Application NDA208910

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 kit in 1 carton * 3.75 g in 1 bottle * 147 mL in 1 bottle65628-204-05Azurity Pharmaceuticals26 January 2018
1 kit in 1 carton * 7.5 g in 1 bottle * 295 mL in 1 bottle65628-205-10Azurity Pharmaceuticals26 January 2018
1 kit in 1 carton * 7.5 g in 1 bottle * 145 mL in 1 bottle65628-206-05Azurity Pharmaceuticals26 January 2018
1 kit in 1 carton * 15 g in 1 bottle * 289 mL in 1 bottle65628-208-10Azurity Pharmaceuticals26 January 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 April 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Vancomycin kit.

Compare 1

Other strengths and forms of Vancomycin

Clinical summary

Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Vancomycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Firvanq kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.